Division director Gynecologic oncology Professor of Obstetrics and Gynecology, University VA School of Medicine
Obstetrics & Gynecology
Dr. Susan C. Modesitt, MD
|
|
Give Review
Susan Modesitt is an expert in the field of Obstetrics & Gynecology. She attended University of Virginia School of Medicine. She has 5 awards "America's Top Doctors", "CMS Meaningful Use Stage 1 Certification", "America's Top Doctors for Cancer", "Fellow (FACOG)" and "Fellow (FACS)". Dr. Susan C. Modesitt is a published doctor. She published 65 publications, including: 'HIV seroprevalence in emergency department patients: Portland, Oregon, 1988-1991.' Doctor Susan C. Modesitt, MD accepts Medicare payments and is registered with Medicare.gov.
Publications
- Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immun...
- Body mass index and mortality in endometrial cancer: A systematic review and meta-analysis.
- Metabolic vulnerabilities in endometrial cancer.
- Hormonal contraceptive use for endometrial cancer prevention: physician attitudes and practices.
- Perceptions of obesity and cancer risk in female bariatric surgery candidates: Highlighting the need for physician action for unsuspectingly obese and high risk patients.
- Desmoplastic small round cell tumor of the ovary: A rare but devastating disease in young women.
- Overcoming platinum resistance in preclinical models of ovarian cancer using the neddylation inhibitor MLN4924.
- What is New in Gynecologic Oncology?: Thought-Provoking Articles From the Past Year.
- Women 50 Years Or Younger With Endometrial Cancer: The Argument for Universal Mismatch Repair Screening and Potential for Targeted Therapeutics.
- A phase II evaluation of motesanib (AMG 706) in the treatment of persistent or recurrent ovarian, fallopian tube and primary peritoneal carcinomas: A Gynecologic Oncol...
- Beyond mere obesity: effect of increasing obesity classifications on hysterectomy outcomes for uterine cancer/hyperplasia.
- Hyperandrogenism of ovarian etiology: utilizing differential venous sampling for diagnosis.
- Not all fat is equal: differential gene expression and potential therapeutic targets in subcutaneous adipose, visceral adipose, and endometrium of obese women with and...
- Frailty: An outcome predictor for elderly gynecologic oncology patients.
- Morbidly obese women with and without endometrial cancer: Are there differences in measured physical fitness, body composition, or hormones?
- Phase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer.
- Risk for residual adenocarcinoma in situ or cervical adenocarcinoma in women undergoing loop electrosurgical excision procedure/conization for adenocarcinoma in situ.
- Retrospective review of an intraoperative algorithm to predict lymph node metastasis in low-grade endometrial adenocarcinoma.
- Hormone replacement therapy in gynecologic cancer survivors: Why not?
- A nomogram for estimating the probability of ovarian cancer.
- Florid endometriosis in a postmenopausal woman.
- Appendiceal pathology at the time of oophorectomy for ovarian neoplasms.
- In vitro and in vivo histone deacetylase inhibitor therapy with vorinostat and paclitaxel in ovarian cancer models: does timing matter?
- Cervical stromal invasion predicting survival in endometrial cancer.
- SGO White Paper on ovarian cancer: etiology, screening and surveillance.
- Pre-operative gynecologic evaluation of bariatric surgery patients: improving cancer detection in a high-risk population.
- Anomalous vasculature in Mayer-Rokitansky-Kuster-Hauser syndrome.
- Suberoylanilide hydroxamic acid (SAHA) potentiates paclitaxel-induced apoptosis in ovarian cancer cell lines.
- Temozolomide in advanced and recurrent uterine leiomyosarcoma and correlation with o6-methylguanine DNA methyltransferase expression: a case series.
- Cancer in obese women: potential protective impact of bariatric surgery.
- Cyclooxygenase-2 in cervical neoplasia: a review.
- Hypodontia as a risk marker for epithelial ovarian cancer: a case-controlled study.
- The effects of abuse on health problems in menopausal women.
- Cervical adenocarcinoma in situ: the predictive value of conization margin status.
- In vitro and in vivo histone deacetylase inhibitor therapy with suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer.
- The treatment of lateral T1 and T2 squamous cell carcinomas of the vulva confined to the labium majus or minus.
- Anastrozole therapy in recurrent ovarian adult granulosa cell tumors: a report of 2 cases.
- Food insecurity among cancer patients in kentucky: a pilot study.
- Endometrial cancer in Kentucky: the impact of age, smoking status, and rural residence.
- Expression of an extracellular matrix metalloproteinase inducer (basigin) in the human ovary and ovarian endometriosis.
- The incidental postmenopausal adnexal mass.
- Concordance of gross surgical and final fixed margins in vulvar intraepithelial neoplasia 3 and vulvar cancer.
- Rate of pathology from atypical glandular cell Pap tests classified by the Bethesda 2001 nomenclature.
- Adverse impact of a history of violence for women with breast, cervical, endometrial, or ovarian cancer.
- Is cytologic screening an effective surveillance method for detection of vaginal recurrence of uterine cancer?
- The impact of obesity on the incidence and treatment of gynecologic cancers: a review.
- Risk of malignancy in unilocular ovarian cystic tumors less than 10 centimeters in diameter.
- Malignant struma ovarii: a case report and analysis of cases reported in the literature with focus on survival and I131 therapy.
- Ovarian and extraovarian endometriosis-associated cancer.
- Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy.
- Functional outcomes and complications of continent urinary diversions in patients with gynecologic malignancies.
- Endovascular management of ureteral-iliac artery fistulae with Wallgraft endoprostheses.
- Serous tubal intraepithelial carcinoma: an incidental finding at the time of prophylactic bilateral salpingo-oophorectomy.
- Vulvar necrotizing soft tissue infection: A review of a multi-disciplinary surgical emergency and management in the modern era.
- Salvage of isolated vaginal recurrences in women with surgical stage I endometrial cancer: a multiinstitutional experience.
- HIV seroprevalence in emergency department patients: Portland, Oregon, 1988-1991.
- In vitro and in vivo adenovirus-mediated p53 and p16 tumor suppressor therapy in ovarian cancer.
- Expression of Ki-67 in vulvar carcinoma and vulvar intraepithelial neoplasia III: correlation with clinical prognostic factors.
- The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC).
- Primary appendiceal cancer: gynecologic manifestations and treatment options.
- Positron emission tomography in a premenopausal asymptomatic woman: a case report of increased ovarian uptake in a benign condition.
- Impact of body mass index on treatment outcomes in endometrial cancer patients receiving doxorubicin and cisplatin: a Gynecologic Oncology Group study.
- A phase II study of vorinostat in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group study.
- Recurrent epithelial ovarian cancer: pharmacotherapy and novel therapeutics.
Schools
Virginia Commonwealth University School Of Medicine
North Carolina Memorial Hospital
MD Anderson Cancer Center
Procedures Preformed
- Abdominal Hysterectomy With Robotic Assistance
- Colpopexy
- Colporrhaphy
- Colposcopy
- View All
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- America's Top Doctors for Cancer
- Fellow (FACOG)
- Fellow (FACS)
Education
-
University of Texas MD Anderson Cancer Center -
University of North Carolina Hospitals -
University of Virginia School of Medicine
Hospital
-
University of Virginia Medical Center
Drug Facts
| NPI NUMBER | 1427070598 | |
| NPPES Provider LastName | MODESITT | |
| NPPES Provider FirstName | SUSAN | |
| NPPES Provider ZIPCode | 229080001 | |
| NPPES Provider State | VA | |
| Specialty Description | Gynecological/Oncology | |
| Total Claim Count | 109.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 14.0 | |
| Percent Opioid Claims | 12.84 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1427070598 |
| Last Name Of The Provider | MODESITT |
| First Name Of The Provider | SUSAN |
| View All |
Similar Doctors
|
Dr. Willie A. Andersen, MD |
|
|
Dr. Leigh A. Cantrell, MD |
|
Dr. Peyton T. Taylor Jr., MD |
|
Dr. Linda R. Duska, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Jacqueline K. Halsey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew T. Montgomery, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carrie E. Sopata, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Amir A. Jazaeri, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Taniqua Miller, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rebecca S. Kightlinger, DO
This Doctor is OpenDoctor Recommended.
|
|
Dr. Devereux N. Saller Jr., MD
This Doctor is OpenDoctor Recommended.
|